| 000 | 01275 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250518062257.0 | ||
| 264 | 0 | _c20191108 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1744-7607 | ||
| 024 | 7 |
_a10.1080/17425255.2019.1673367 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yali | |
| 245 | 0 | 0 |
_aCurrent and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. _h[electronic resource] |
| 260 |
_bExpert opinion on drug metabolism & toxicology _cOct 2019 |
||
| 300 |
_a813-829 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
| 700 | 1 | _aDe Clercq, Erik | |
| 700 | 1 | _aLi, Guangdi | |
| 773 | 0 |
_tExpert opinion on drug metabolism & toxicology _gvol. 15 _gno. 10 _gp. 813-829 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17425255.2019.1673367 _zAvailable from publisher's website |
| 999 |
_c30147010 _d30147010 |
||